About Prolaio
Prolaio is a company based in Jacksonville (United States) founded in 2021 was acquired by Kardigan in March 2025.. Prolaio has raised $25.5 million across 1 funding round from investors including Kardigan. Prolaio offers products and services including Prolaio Platform and FDA-Cleared Algorithms. Prolaio operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Jacksonville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prolaio
Prolaio offers a comprehensive portfolio of products and services, including Prolaio Platform and FDA-Cleared Algorithms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Secure platform for remote heart health data collection and analysis.
Algorithms that predict cardiovascular conditions for better clinical decisions.
Unlock access to complete
Funding Insights of Prolaio
Prolaio has successfully raised a total of $25.5M through 1 strategic funding round. The most recent funding activity was a Series B round of $25.5 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $25.5M
-
First Round
First Round
(26 Jul 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series B - Prolaio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prolaio
Prolaio has secured backing from 1 investor. Prominent investors backing the company include Kardigan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech company developing personalized medicines for cardiovascular diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prolaio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prolaio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prolaio Comparisons
Competitors of Prolaio
Prolaio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| domain | founded_year | HQ Location |
Regulatory support, brand differentiation, and prototyping services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Prolaio
When was Prolaio founded?
Prolaio was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Prolaio located?
Prolaio is headquartered in Jacksonville, United States.
Is Prolaio a funded company?
Prolaio is a funded company, having raised a total of $25.5M across 1 funding round to date. The company's 1st funding round was a Series B of $25.5M, raised on Jul 26, 2023.
What does Prolaio do?
Company offers prescriptive analytics for pharmaceutical Industry. It utilize data science and biomarkers to develop solutions for pharmaceutical.
Who are the top competitors of Prolaio?
Prolaio's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
What products or services does Prolaio offer?
Prolaio offers Prolaio Platform and FDA-Cleared Algorithms.
Who are Prolaio's investors?
Prolaio has 1 investor. Key investors include Kardigan.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.